DRAP seeks explanation from UHS VC
LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has sought explanation from the University of Health Sciences (UHS) vice chancellor for initiating clinical trials of vaccines without prior approval from Division of Pharmacy Services, DRAP.
In a note to UHS Vice Chancellor Prof Dr Javed Akram, DRAP said University of Health Sciences neither applied to Director Division of Pharmacy Services/Chairman Clinical Committee to conduct clinical trials of vaccines nor any clinical trials has been approved by the committee.
DRAP directed the UHS VC to stop clinical study on vaccines immediately and explain his position within three days for starting clinical trials without approval from the Clinical Study Committee, Division of Pharmacy Services, DRAP.
-
Brooklyn Beckham Set To Make More Bombshell Claims In Prince Harry Style: Deets -
Prince William Arrives In Bristol To See UK's Most Poweful Supercomputer Isambard-AI -
Dog Dies After Florida Woman Allegedly Sets Neighbour’s House On Fire -
AI Will Create Jobs, Not Just Replace Them, Says Nvidia CEO -
Hyundai Labour Rebels Against Robot Deployment, Warns Of Employment Risks -
Reviving The ‘Golden Era’: How The New UK-China Partnership Seeks To Strengthen Bilateral Economic Ties -
Prince Harry Shows Support To Elizabeth Hurley In Court After His Emotional Testimony -
Amelia Gray Reflects On Her Unconventional Career Journey -
Heath Ledger, 'Dark Knight' Star, Remembered On 18th Anniversary -
Trump Launches ‘Board Of Peace’ In Davos: Inside Governance, Mandate & Members -
Martin Short Almost Ruined Key Moment Of Selena, Benny's Wedding: Deets -
This Pixel Phone Feature May Leak Your Calls: Report -
Ubisoft: Shares Plunge Amid Restructuring Plan And Wave Of Games Cancellations -
Meghan Markle 'not Anxious' About Prince Harry Moving To UK: Here's Why -
Vaccines May Do Far More Than Prevent Infections -
Apple Plans To Roll Out Siri AI Chatbot By 2026